Our focus is synaptic transmission — the process by which nerve cells communicate. Changes in synaptic transmission are believed to be key features of many neurodegenerative and neuropsychiatric diseases. Because of this, drugs that modulate synaptic transmission are likely to dramatically impact these diseases. At Galenea, we have made developing such drugs our goal.
At Galenea, we foster a vibrant, engaging, and collaborative environment and consider career growth and development a high priority.
Learn more about CAREERS at Galenea.